Analysis: Rapid infusion of infliximab safe, possibly beneficial in IBD

07/17/2013 | Healio

Researchers who looked at findings from 10 studies found rapid infusions of infliximab did not raise risks among patients with inflammatory bowel disease and other other conditions, compared with standard infusions. In addition, University of Michigan researchers reported that nine of the studies, seven of which were focused on IBD patients, suggested a reduced reaction risk when comparing rapid and standard infusion.

View Full Article in:

Healio

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ